# Prostate Cancer Foundation

Source: https://onco.cc/institutions/pcf/  
OnCo record `pcf` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The foundation Michael Milken started in 1993 after his own diagnosis; it funds prostate cancer research worldwide and helped pay for the science behind two of the drugs men now take.

## Summary

Founded in 1993 by Michael Milken after he was diagnosed with advanced prostate cancer, the Prostate Cancer Foundation funds investigators and teams rather than running its own labs. Its history page credits $8 million of PCF funding toward the development of abiraterone (Zytiga) and $14.75 million toward enzalutamide (Xtandi), and a $65 million partnership with the US Department of Veterans Affairs in 2016 that set up 22 precision oncology centres of excellence for veterans. PCF runs Young Investigator and Challenge awards, an annual scientific retreat, and awareness campaigns. Headquartered in Santa Monica, California.

## Fields

- Kind: Institution
- Last checked: 2026-09-10
- Also known as: PCF; CaP CURE
- City: Santa Monica, CA, US
- Type: consortium
- Website: https://www.pcf.org

## Sources

- PCF: our history: https://www.pcf.org/about/our-history/

## Connected records

- collections: [Prostate Cancer Foundation (PCF)](https://onco.cc/collections/prostate-cancer-foundation/)
- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- drugs: [Abiraterone acetate](https://onco.cc/drugs/abiraterone/), [Enzalutamide](https://onco.cc/drugs/enzalutamide/)
- people: [Charles L. Sawyers](https://onco.cc/people/charles-sawyers/), [David H. Koch](https://onco.cc/people/david-koch/), [Michael Milken](https://onco.cc/people/michael-milken/)
- bottlenecks: [Funding follows fashion, not burden](https://onco.cc/bottlenecks/b-funding-allocation/), [The valley of death between lab and product](https://onco.cc/bottlenecks/b-translational-valley/)

---
JSON: https://onco.cc/api/v1/entities/pcf.json